Critique of the analysis of the time course for the antimigraine effect of ubrogepant 50 mg. Clinical relevance versus statistical significance.
Peer Tfelt-HansenAnika HüsingHans-Christoph DienerPublished in: Cephalalgia : an international journal of headache (2021)
Keyphrases